Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
Apply
Lenvatinib & Pembrolizumab
Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step